RECRUITING

Cerebellar Involvement in Alcohol Use Disorder (AUD)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this observational and interventional study is to better understand the involvement of the cerebellum in the brain reward system in persons with alcohol use disorder (AUD). The main questions it aims to answer are: 1. What is the nature of cerebellar input to the ventral tegmental area (VTA) in the brain reward system, and how is it perturbed in AUD? 2. What is the relationship between measures of cerebellar integrity and magnitude of reward activation to alcohol-related cues in cerebellar, VTA and other brain reward structures? 3. What is the therapeutic potential of cerebellar transcranial direct current stimulation (tDCS) for modulating alcohol cue reactivity, associated alcohol craving, and cerebellar - VTA functional connectivity in the brain reward system? Persons with AUD will be compared with healthy control participants.

Official Title

Investigation of Cerebellar Involvement in AUD

Quick Facts

Study Start:2023-10-12
Study Completion:2027-09
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05732207

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:25 Years to 55 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * completed at least 8 years of education
  1. * Estimated Intelligence Quotient (IQ) \< 90
  2. * less than 5th grade reading level
  3. * Left handed
  4. * Non-native English speaker
  5. * current drug use disorder other than alcohol (except nicotine and caffeine) and or recent drug use in the last 90 days
  6. * Positive breath alcohol level at time of MRI scan or discrepancies between alcohol biomarker and self-report that cannot be resolved
  7. * Exhibiting symptoms of alcohol withdrawal on visit 1 assessment
  8. * Significant current psychiatric distress and or treatment
  9. * History of any central nervous system disorder, presence of a seizure disorder, or use of anticonvulsant medication in the past 3 months
  10. * any serious medical condition detected on assessment or by medical record review; or have liver function tests more than three times normal at screening
  11. * History of metal implantation that would preclude MRI scanning; or other implants, pumps, pacemakers that would be contraindications for MRI scanning
  12. * Abnormal MRI scan or history of significant closed head trauma
  13. * Evidence of dementia
  14. * For women, pregnancy

Contacts and Locations

Study Contact

John E Desmond, PhD
CONTACT
410-502-3583
jdesmon2@jhmi.edu
JoAnna Mathena
CONTACT

Principal Investigator

John E Desmond, PhD
PRINCIPAL_INVESTIGATOR
Johns Hopkins University

Study Locations (Sites)

Johns Hopkins University School of Medicine
Baltimore, Maryland, 21205
United States

Collaborators and Investigators

Sponsor: Johns Hopkins University

  • John E Desmond, PhD, PRINCIPAL_INVESTIGATOR, Johns Hopkins University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-10-12
Study Completion Date2027-09

Study Record Updates

Study Start Date2023-10-12
Study Completion Date2027-09

Terms related to this study

Keywords Provided by Researchers

  • AUD
  • heavy drinking
  • hazardous drinking

Additional Relevant MeSH Terms

  • Alcohol Use Disorder